Cite
Concurrent chemoradiation therapy with docetaxel (DOC) for laryngeal preservation in T2N0M0 glottic squamous cell carcinomas.
MLA
Furusaka, Tohru, et al. “Concurrent Chemoradiation Therapy with Docetaxel (DOC) for Laryngeal Preservation in T2N0M0 Glottic Squamous Cell Carcinomas.” Acta Oto-Laryngologica, vol. 133, no. 1, Jan. 2013, pp. 99–112. EBSCOhost, https://doi.org/10.3109/00016489.2012.717179.
APA
Furusaka, T., Matsuda, A., Saito, T., Katsura, Y., & Ikeda, M. (2013). Concurrent chemoradiation therapy with docetaxel (DOC) for laryngeal preservation in T2N0M0 glottic squamous cell carcinomas. Acta Oto-Laryngologica, 133(1), 99–112. https://doi.org/10.3109/00016489.2012.717179
Chicago
Furusaka, Tohru, Akira Matsuda, Tsutomu Saito, Yoshihisa Katsura, and Minoru Ikeda. 2013. “Concurrent Chemoradiation Therapy with Docetaxel (DOC) for Laryngeal Preservation in T2N0M0 Glottic Squamous Cell Carcinomas.” Acta Oto-Laryngologica 133 (1): 99–112. doi:10.3109/00016489.2012.717179.